$8.6 Billion Global Drug Screening Market 2018-2022 by Product, Drug Screening Services, Sample Type, and End User - ResearchAndMarkets.com

DUBLIN--()--The "Drug Screening Market by Product, Drug Screening Services, Sample Type, End User - Global Forecast to 2022" report has been added to ResearchAndMarkets.com's offering.

The global drug screening market is projected to reach USD 8.63 Billion by 2022 from USD 5.32 Billion in 2017, at a CAGR of 10.2%.

Factors such as growing drug & alcohol consumption, enforcement of stringent laws mandating drug and alcohol testing, and regulatory approvals and new product & service launches are driving the growth of the market.

The market is dominated by North America, followed by Europe, Asia Pacific, and the Rest of the World (RoW). The dominance of the North American market is attributed to factors such as rising consumption of illicit drugs, availability of government funding to curb drug abuse, and the presence of laws supporting drug screening, and growing burden of accidents due to unsafe levels of alcohol consumption.

Prominent players offering drug screening products include Alere (US), Thermo Fisher (US), Drgerwerk (Germany), OraSure (US), Alfa Scientific Designs (US), Lifeloc (US), MPD, Inc. (US), Premier Biotech (US), Shimadzu (Japan), Siemens Healthineers (US). While, LabCorp (US), Quest Diagnostics (US), Omega Laboratories (US), Psychemedics (US), CRL (US), SureHire (Canada), and CannAmm (Canada) are some of key players offering drug screening services.

Market Dynamics

Drivers

  • Growing Drug & Alcohol Consumption
  • Enforcement of Stringent Laws Mandating Drug and Alcohol Testing
  • Presence of Government Funding in Major Markets
  • Regulatory Approvals & Product Launches and Services

Restraints

  • Ban on Alcohol Consumption in Several Islamic Countries
  • Prohibition of Workplace Drug Testing in Some Countries

Opportunities

  • Oral Fluid Testing
  • Emergence of Fingerprint-Based Drug Screening
  • Emerging Economies

Challenges

  • Accuracy and Specificity Concerns Related to Breathalyzers

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 Drug Screening Market, by Product & Service

7 Drug Screening Market, by Sample Type

8 Drug Screening Market, by End User

9 Drug Screening Market, by Region

10 Competitive Landscape

11 Company Profiles

  • Alere
  • Alfa Scientific Designs
  • Drgerwerk
  • Labcorp
  • Lifeloc
  • MPD Inc.
  • Omega Laboratories
  • Orasure
  • Premier Biotech
  • Psychemedics
  • Quest Diagnostics
  • Roche
  • Shimadzu
  • Siemens Healthineers
  • Thermo Fisher Scientific

For more information about this report visit https://www.researchandmarkets.com/research/phtsxd/8_6_billion?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Drug Abuse Screening

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Drug Abuse Screening